Image
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Back to top
Dr Elena Nikiphorou
Consultant Rheumatologist
Dr Elena Nikiphorou is a consultant rheumatologist at King’s College Hospital, London, UK, and an adjunct senior lecturer at King’s College London, UK.
Dr Nikiphorou has a clinical and academic interest in inflammatory arthritis, multi-morbidity and long-term outcomes of disease. She has been the recipient of multiple national and international awards, bursaries and competitive roles. She has been involved in the development of several international recommendations, including on the management of difficult-to-treat rheumatoid arthritis, axial spondyloarthritis and self-management strategies in inflammatory arthritis.
0 resources
Video3 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
EU-DA-2400669
Video2 minutes watch
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
EU-DA-2400668
Video2 minutes watch
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.
EU-DA-2400666
Video1 minute watch
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
EU-DA-2400662
Article3 minutes read
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
EU-DA-2400660